Will ich der Vollständigkeit halber noch einfügen. Aber Herr Bronco, Doc B. und andere haben sich schon vor Jahren mit der Nanotechnologie auseinandergesetzt. Wenn dann so ein Glücksfall und die Rallye da ist, heisst es zugreifen, schliesslich hat man Jahre in die Ecke geschielt.
George B. hat Mitte Dezember 2003 3,6 Milliarden locker gemacht für die Nanos, das war halt das Signal.
Gruss E.
chart.bigcharts.com/bc3/quickchart/...92&mocktick=1&rand=9726"
New Equipment for Production of Nanoparticles, Microfluidizer Processor Line, and Recent Enhancements Featured in Interview with MFIC CEO, Irwin Gruverman
NEWTON, Mass., Dec 1, 2003 (BUSINESS WIRE) -- At the request of
CEOCFOinterviews.com, Irwin Gruverman, CEO and Chairman of MFIC Corporation
("MFIC" or the "Company") was interviewed by Walter Banks on the subject of
MFIC's line of Microfluidizer(R) materials processing equipment, recent
enhancements to this line, the introduction of a value priced high throughput
production model, and its new, patented, Multiple Stream Mixer Reactor device
for creation of nanoparticles and nanomaterials ("MMR").
MFIC provides leading edge high performance mixing and formulation equipment
available to the biotech, pharmaceuticals, coatings, paint, chemical and food
industries.
The full interview can be found at the Company's website:
www.mficcorp.com and
serves to familiarize investors with MFIC, furnishing them insight into the
Company's background, performance, prospects and products while also providing
an update to the October, 2002 interview with the same publisher. The in-depth
interviews conducted by CEOCFOinterviews are geared toward sophisticated
investors who require unbiased, unscripted first-hand perspective to assist them
in making informed investment decisions.
Mr. Gruverman discussed MFIC's Microfluidizer high performance materials
processing equipment, operating at the highest available pressures for high
shear processing of fluids. The uniform, submicron structures created allow
preparation of commercial products having unmatched uniformity, stability and
reliability. Examples include injectable emulsions, ink-jet inks, finish paints,
and soft drinks. In addition, Microfluidizer processors are the standard means
of cell disruption for recovery of proteins produced by biotechnology processes
and are widely used in genomics applications. He also discussed and elaborated
upon the recently introduced MMR for continuous chemical reaction in an
ultraturbulent environment, and emphasized the ability of MMR to efficiently
create production quantities of nanoparticles. This ability will enable the
large-scale applications of these valuable materials. MMR's impact on MFIC's
growth and profitability could be large.
Mr. Gruverman discussed the recent introduction of product enhancements and
features including:
-- M700 Microfluidizer Containment System, which is utilized for
the processing of highly toxic cancer drugs and other
hazardous materials. The first such recently installed system
is now producing pharmaceutical product.
-- M700 Microfluidizer Split System (separating the power source
from the mixing/processing apparatus) accommodates demands of
limited space within clean rooms and for noise abatement
within pharmaceutical production facilities. In conjunction
with this system, a Level II Steam Sterility Option was
introduced for fitting to systems used for production of
injectable and other pharmaceuticals. This option enables
compliance with stringent regulatory production requirements.
We have recently delivered such a system to a pharmaceutical
manufacturer.
-- Ultra Clean in Place (UCIP) option, which improves the ability
to clean in place (CIP) Microfluidizer systems between product
batch runs or before storage. This capability differentiates
our Microfluidizer materials processor systems from all other
competitive products. Several pilot and production systems
incorporating this option have already been delivered.
Mr. Gruverman also discussed the price and competitive advantages of the M710,
MFIC's newest high throughput production system. This system is designed to
materially enhance our competitive position in terms of pricing and performance
in all industries and applications that we serve. In addition to biotechnology
and pharmaceutical production, this product targets markets such as foods,
chemicals and personal care products, by offering pricing that is more
competitive with traditional homogenizers, along with MFIC's superior fluid
processing technology. The M710 systems will improve our margins and delivery
times significantly. More than twelve sales quotations for these systems have
already been made to existing and prospective customers.
Mr. Gruverman also extensively discussed MFIC's patented Multiple Stream
Mixer-Reactor (MMR) system which functions as a continuous chemical reactor.
MFIC believes that MMR technology enables a new unit operation in chemical
engineering practice. The device allows chemical reactions to occur under
ultraturbulent mixing conditions, with no premixing. Such operations are also
known as Collision Reaction Processing. These systems can be configured for
continuous production of nanoparticles. MFIC is proceeding with projects
involving other companies seeking to optimize or enable drug delivery, catalysts
and coatings products, as well as an internal program on nanopolymer creation
for drug delivery and other applications. MFIC expects to deliver the first MMR
laboratory development systems (in the $200,000-$250,000 sales price range) in
2004, with production systems (in the $750,000 - $1,000,000 plus sales price
range) in late 2004 or 2005. The Company believes that it is a leader in the
technology of systems for continuous production of uniform, reproducible,
microparticles, nanoparticles and nanodroplets.
Marketing and sales are centralized and a strong core team leads an extensive
network of agents and distributors in North America, Europe and Asia. About 75%
of Microfluidizer system sales are to the pharmaceutical and biotech industries.
Most sales are to Fortune 500 companies.
Management believes that this release contains forward-looking statements that
are subject to certain risks and uncertainties including statements relating to
the Company's plan to maintain and/or increase operating profitability. Such
statements are based on management's current expectations and are subject to a
number of factors and uncertainties that could cause actual results achieved by
the Company to differ materially from those described in the forward-looking
statements. The Company cautions investors that there can be no assurance that
the actual results or business conditions will not differ materially from those
projected or suggested in such forward-looking statements as a result of various
factors, including but not limited to, the following risks and uncertainties:
(i) whether the performance advantages of the Company's Microfluidizer(R)
materials processing equipment will be realized commercially or that a
commercial market for the equipment will continue to develop, (ii) whether the
Company will have access to sufficient working capital through continued and
improving cash flow from sales and ongoing borrowing availability, the latter
being subject to the Company's ability to comply with the covenants and terms of
the Company's loan agreement with its senior lender, (iii) whether the Company's
expectation that the benefits of nanotechnology will, in part, be realized by
the ability of the MMR to produce innovative materials in large quantities, and
(iv) whether the Company's is able to increase the number of prototype MMR
placements and then manufacture and introduce commercial production MMR
equipment.
MFIC CORPORATION
MFIC Corporation, through its Microfluidics Division, provides patented and
proprietary, high performance Microfluidizer(R) materials processing equipment
to the chemical, pharmaceutical, biotechnology, cosmetic/personal care, and food
processing industries. Through its divisions, the Company provides leading
equipment, and innovative technology and solutions to the chemicals, paints,
pigments and coatings industries for milling, deagglomeration and dissolving.
The combined resources and capabilities of the Company's equipment lines are
used to provide comprehensive solutions for materials processing.
SOURCE: MFIC Corporation